share_log

Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target

Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target

Chardan Capital重申买入Tenaya Therapeutics,维持20美元的目标股价
Moomoo 24/7 ·  03/21 12:52

Chardan Capital analyst Geulah Livshits reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $20 price target.

查尔丹资本分析师吉拉·利夫希茨重申Tenaya Therapeutics(纳斯达克股票代码:TNYA)的买入并维持20美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发